Published in Virology on September 15, 2002
Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol (2009) 3.19
Patterns of intra- and interhost nonsynonymous variation reveal strong purifying selection in dengue virus. J Virol (2003) 2.98
Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc Natl Acad Sci U S A (2008) 2.51
Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J Virol (2005) 2.35
Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia. PLoS Negl Trop Dis (2010) 2.17
Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A (2005) 2.02
Endemic dengue associated with the co-circulation of multiple viral lineages and localized density-dependent transmission. PLoS Pathog (2011) 1.87
Myanmar dengue outbreak associated with displacement of serotypes 2, 3, and 4 by dengue 1. Emerg Infect Dis (2004) 1.68
Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J Virol (2010) 1.58
Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. J Virol (2010) 1.51
Dengue--quo tu et quo vadis? Viruses (2011) 1.50
Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology (2006) 1.49
Dengue-1 virus clade replacement in Thailand associated with enhanced mosquito transmission. J Virol (2011) 1.42
Superior infectivity for mosquito vectors contributes to competitive displacement among strains of dengue virus. BMC Ecol (2008) 1.41
Virus variation resources at the National Center for Biotechnology Information: dengue virus. BMC Microbiol (2009) 1.36
Molecular epidemiology of dengue viruses in southern China from 1978 to 2006. Virol J (2011) 1.29
Diverse dengue type 2 virus populations contain recombinant and both parental viruses in a single mosquito host. J Virol (2003) 1.29
Defective interfering viral particles in acute dengue infections. PLoS One (2011) 1.25
Importation of dengue virus type 3 to Japan from Tanzania and Cote d'Ivoire. Emerg Infect Dis (2010) 1.24
RNA virus genomics: a world of possibilities. J Clin Invest (2009) 1.23
Asymmetric competitive suppression between strains of dengue virus. BMC Microbiol (2008) 1.21
Sources of dengue viruses imported into Queensland, australia, 2002-2010. Emerg Infect Dis (2012) 1.21
Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient. J Gen Virol (2007) 1.16
Genetic diversity of the E protein of dengue type 3 virus. Virol J (2009) 1.15
Co-circulation of two genotypes of dengue virus serotype 3 in Guangzhou, China, 2009. Virol J (2012) 1.14
Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections. Front Immunol (2014) 1.13
Viral and epidemiological determinants of the invasion dynamics of novel dengue genotypes. PLoS Negl Trop Dis (2010) 1.12
Evolutionary history and molecular epidemiology of rabbit haemorrhagic disease virus in the Iberian Peninsula and Western Europe. BMC Evol Biol (2010) 1.11
Re-emergence of dengue virus type 3 in Canton, China, 2009-2010, associated with multiple introductions through different geographical routes. PLoS One (2013) 1.10
Strategically examining the full-genome of dengue virus type 3 in clinical isolates reveals its mutation spectra. Virol J (2005) 1.06
Comparative analysis of full genomic sequences among different genotypes of dengue virus type 3. Virol J (2008) 1.04
Understanding the dengue viruses and progress towards their control. Biomed Res Int (2013) 1.02
Simultaneous circulation of genotypes I and III of dengue virus 3 in Colombia. Virol J (2008) 1.02
Molecular epidemiological and virological study of dengue virus infections in Guangzhou, China, during 2001-2010. Virol J (2013) 1.01
New genotype of dengue type 3 virus circulating in Brazil and Colombia showed a close relationship to old Asian viruses. PLoS One (2009) 1.00
Dengue virus type 1 clade replacement in recurring homotypic outbreaks. BMC Evol Biol (2013) 0.97
Dengue virus type 3, Cuba, 2000-2002. Emerg Infect Dis (2005) 0.92
Complete genome sequence of dengue virus serotype 3 from guangzhou, china. Genome Announc (2013) 0.89
Prolonged co-circulation of two distinct Dengue virus Type 3 lineages in the hyperendemic area of Medellin, Colombia. Am J Trop Med Hyg (2010) 0.86
Evolutionary Analysis of Dengue Serotype 2 Viruses Using Phylogenetic and Bayesian Methods from New Delhi, India. PLoS Negl Trop Dis (2016) 0.83
Distribution of fitness in populations of dengue viruses. PLoS One (2014) 0.83
Specific genetic markers for detecting subtypes of dengue virus serotype-2 in isolates from the states of Oaxaca and Veracruz, Mexico. BMC Microbiol (2008) 0.83
Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico. BMC Microbiol (2009) 0.83
Dengue virus 2 American-Asian genotype identified during the 2006/2007 outbreak in Piauí, Brazil reveals a Caribbean route of introduction and dissemination of dengue virus in Brazil. PLoS One (2014) 0.81
Phylogenetic relationship of dengue virus type 3 isolated in Brazil and Paraguay and global evolutionary divergence dynamics. Virol J (2012) 0.79
Genetic variation in the 3' untranslated region of dengue virus serotype 3 strains isolated from mosquitoes and humans in Brazil. Virol J (2013) 0.78
Evolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization. J Infect Dis (2015) 0.78
Molecular Epidemiology of Dengue Viruses Co-circulating in Upper Myanmar in 2006. Trop Med Health (2014) 0.78
Emergence of a new lineage of Cache Valley virus (Bunyaviridae: Orthobunyavirus) in the Northeastern United States. Am J Trop Med Hyg (2015) 0.77
Nature and Extent of Genetic Diversity of Dengue Viruses Determined by 454 Pyrosequencing. PLoS One (2015) 0.76
Insights into the molecular evolution of Dengue virus type 4 in Puerto Rico over two decades of emergence. Virus Res (2015) 0.76
Competitive advantage of a dengue 4 virus when co-infecting the mosquito Aedes aegypti with a dengue 1 virus. BMC Infect Dis (2016) 0.75
DGV: Dengue Genographic Viewer. Front Microbiol (2016) 0.75
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg (1989) 10.52
HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21
A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg (1988) 8.54
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Neurological manifestations of dengue infection. Lancet (2000) 5.69
Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg (1987) 5.53
Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13
Early clinical and laboratory indicators of acute dengue illness. J Infect Dis (1997) 5.00
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88
The epidemic behavior of the hepatitis C virus. Science (2001) 4.81
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Etiology of interepidemic periods of mosquito-borne disease. Proc Natl Acad Sci U S A (2000) 4.75
Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg (1988) 4.65
Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg (1969) 4.41
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
Evolutionary aspects of recombination in RNA viruses. J Gen Virol (1999) 3.74
Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
Extinction rates can be estimated from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1994) 3.47
Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol (1982) 3.44
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg (1999) 3.11
Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis (1999) 2.96
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A (2006) 2.77
Japanese encephalitis. J Neurol Neurosurg Psychiatry (2000) 2.76
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. Am J Trop Med Hyg (2001) 2.67
Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis (1985) 2.59
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Ecology and evolution of rabies virus in Europe. J Gen Virol (1999) 2.52
Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J Clin Microbiol (1998) 2.50
Causes of HIV diversity. Nature (1995) 2.48
Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45
Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet (1998) 2.41
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
Inferring population history from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1995) 2.21
A likelihood method for the detection of selection and recombination using nucleotide sequences. Mol Biol Evol (1997) 2.20
Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature (2001) 2.20
Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol (2002) 2.18
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens (2002) 2.18
Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA (1993) 2.17
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A (1999) 2.12
Dengue d chikungunya virus infection in man in Thailand, 1962-1964. II. Observations on disease in outpatients. Am J Trop Med Hyg (1969) 2.11
Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol (1999) 2.10
Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol (1982) 2.10
Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol (2001) 2.09
The role of MCM proteins in the cell cycle control of genome duplication. Bioessays (1996) 2.09
Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg (1969) 2.07
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg (1991) 2.06
Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol (2002) 2.04
Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med (1988) 2.03
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer (1994) 1.95
Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics (1999) 1.93
Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol (2001) 1.92
Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am J Trop Med Hyg (1997) 1.90
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis (1999) 1.82
Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences. J Virol Methods (2001) 1.81
Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80
Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol (1999) 1.79
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine (2001) 1.79
Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus. Clin Diagn Lab Immunol (1997) 1.78
Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. Am J Trop Med Hyg (1997) 1.75
Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol (2000) 1.74
Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol (1985) 1.73